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Abstract— Remote ambulatory monitoring is widely seen as 
playing a key part in addressing the impending crisis in health 
care provision. We describe two mobile health solutions, one 
developed in the Netherlands and one in Australia. In both 
cases patients’ biosignals are measured by means of body worn 
sensors which communicate wirelessly with a handheld device. 
Alarms and biosignals can be transmitted over wireless 
communication links to a remote location, and a remote 
health professional can view the biosignals via a web 
application. The clinical purposes are similar, however the 
technological approaches differ in some respects. We compare 
the two approaches and the experience gained working with a 
number of different patient groups and clinical specialties 
during trials in Europe and Australia. 
Keywords-Telemonitoring, teletreatment, mobile technology, 
mobile healthcare solutions, Personal health monitoring 
I.  INTRODUCTION 
M-health systems offer personalised healthcare services 
to the patient whilst promising to alleviate pressure on the 
overburdened healthcare system by improving daily disease 
management, enabling automatic emergency and trend 
detection and facilitating self-care. Many m-health systems 
are already in routine clinical use, typically incorporating a 
wearable or implanted device and running embedded 
software to perform a specific set of functions around one 
clinical application. We distinguish monitoring services from 
services which also provide some kind of treatment or 
intervention. Pacemakers, for example, combine monitoring 
with intervention. Such a system runs autonomously and 
transparently (the patient need not be aware of it or interact 
with it) in contrast with personal health systems where the 
patient actively interacts with the system; hence we 
distinguish also personal mobile services used by the patient 
to aid daily self-care. Local, personal services, which may be 
delivered by a standalone mobile system, are distinguished 
from teleservices, which involve long range communication 
with a remote healthcare location or health professional. 
Many current systems are closed proprietary systems 
which provide a specific set of condition-specific services, 
eg. monitoring and disease management functions. In this 
paper we present a more generic, open approach which we 
believe will lead to more flexible and adaptable personal and 
telehealth services in future. We examine two different 
generic approaches developed by two groups of researchers.  
Researchers at University of Twente in the Netherlands 
have been investigating the application of Body Area 
Network (BAN) technology in a number of clinical settings 
in order to offer remote monitoring and treatment services. 
The Dutch system is known as MobiHealth. Several variants 
were developed during a number of projects starting with 
IST MobiHealth [1-2] and currently continuing in MYOTEL 
[3]. Fig. 1 shows the MYOTEL teletreatment BAN. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Myotel teletreatment BAN 
An alternative approach is applied at the University of 
Technology, Sydney, where a Personal Health Monitor 
(PHM), focusing on local, personal m-health services, has 
been developed and applied in various clinical settings [4-6].  
With both systems the patient wears a sensor network 
and uses a handheld device which receives output from the 
sensor systems, runs a local application and acts as a 
communications gateway for (possible) onward transmission 
of data to a remote healthcare location. In the Australian 
system (Fig. 2) the handheld device is a Microsoft Windows 
mobile phone. The European system has been implemented 
on a number of different PDAs and mobile phone platforms. 
The two approaches share similar clinical goals, namely 
provision of routine chronic disease management 
functionality and/or detection of medical emergencies in 
different clinical settings. In both cases the philosophy is to 
design a generic mobile solution which can be adapted to 
different clinical applications, which is easy to wear and use 
and is as unobtrusive as possible. 
However the two teams utilise different approaches and 
different development technologies. In this paper we present 
the two approaches and compare the experience gained 
working with different patient groups and different clinical 
specialties in Europe and Australia. 
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Figure 2.  Personal Health Monitor  
In Section II a generic architecture for m-health systems 
is presented. In III this architecture is used to compare the 
two systems. Section IV describes the clinical applications 
developed so far by the two teams, V compares experience 
with users and VI presents discussion and conclusions. 
II. A GENERIC ARCHITECTURE FOR M-HEALTH 
Here we describe a high level architecture (Fig. 3) and 
terminology originally developed as part of the European 
research and apply it to compare the two systems and to test 
the genericity of the architecture. We view a BAN-based m-
health system as a set of BANs and a Back End. 
Communication between BANs and the Back End is via so-
called extraBAN communication. To support pervasive 
services and full user mobility, extraBAN communication 
should be wireless. IntraBAN communication may be wired, 
wireless or a mixture of the two. A health BAN is defined as 
a network of communicating devices worn on, around or in 
the body which provides mobile health services to the user. 
A BAN consists of a Mobile Base Unit (MBU) and a set of 
BAN devices (e.g. sensors, actuators or other ‘wearable 
devices’). The MBU acts as a processing platform and 
communications gateway and is currently realised as a 
software application running on a handheld device. BAN 
data may be processed locally within the BAN and/or 
remotely. Front-end supported sensors are powered by a 
sensor front end which also digitizes and filters the raw 
analogue signal before transmitting the data over a wireless 
link to the MBU. A health BAN may act as a standalone 
device providing personal local services to the patient. At the 
other end of the spectrum, all BAN data may be transmitted 
onward for processing, or a combination of local and remote 
processing may be used. If a remote user and extraBAN 
communications are involved then we can regard the m-
health service as a telemedicine service. 
 
Figure 3.  Generic architecture for sensor network systems for m-health 
In the Back End we distinguish functions which are 
concerned with management of BANs, their devices and 
BAN data from the clinical back end functions, which 
support application specific functionality and which may 
interface to healthcare providers’ information systems. 
III. COMPARISON OF THE IMPLEMENTED SYSTEMS 
Here we compare the two systems according to the 
architectural concepts outlined in Section II. Table I lists the 
respective features of the two systems in respect of the BAN.  
TABLE I.  TWO SYSTEMS BY ARCHITECTURAL COMPONENTS: BAN 
PHM MobiHealth 
BAN devices     
• Off-the-shelf sensor 
systems (front end 
supported). Sensors are 
non-invasive, good 
quality/price ratio, 
Bluetooth enabled. 
• Sensors: 1 channel ECG, 
accelerometer, blood 
pressure monitor, blood 
glucose meter, pulse 
oximeter, weight scale. 
• Other: GPS.  
• Sensors, actuators, any 
other wearable device with 
(wireless or wired) 
communications interface.  
• Sensors: 3, 4 and 9 channel 
ECG, surface EMG,  pulse 
oximeter, respiration 
sensor, temperature sensor, 
activity sensors (step-
counter, 3Daccelerometer). 
• Actuators: tactile feedback. 
• Other: GPS, alarm button. 
Sensor Front End 
• Subcomponent of 
commercial sensor 
system incorporating 
embedded software for 
signal processing. 
• Commercial sensor Front 
Ends (re)developed by 
industrial partners, with 
some programming of DSP 
to perform biosignal and 
other processing. 
MBU 
• Any smart phone running 
MS Windows Mobile. 
• Various mobile phones and 
PDAs. 
• Mobile platform running 
Java VM and RMI. 
Software on the MBU 
• Generic interface 
showing live data, 
reminders, battery status. 
• Admin. interface to 
configure reminders, 
sensors. 
• Algorithms to analyse 
ECG and advise user.  
• Application specific 
functionality and GUI 
running over generic BAN 
software layer and protocol 
stack. Example: seizure 
detection algorithm for 
epilepsy. 
Processing on the MBU 
• Philosophy: process 
locally all that can be 
automated and within 
processing capabilities of 
the mobile phone, to limit 
transfer of unnecessary 
data and provide 
immediate feedback. 
• Positioning (also indoors) 
using WiFi, GSM cell-id 
and GPS. 
• Personalisation of sensor 
thresholds and emergency 
settings. 
• Customized audio 
warnings and informative 
messages. 
• Reminders per sensor. 
• Philosophy: design and 
optimize total chain of 
processing for each 
specific application; 
attempt to manage QoS in 
wireless and mobile 
environment by 
performing dynamic task 
(re)allocation across the m-
health service platform 
including the MBU. 
• Positioning (outdoors) 
using cell-id and GPS. 
• Context aware applications 
(adaptation to context 
including communications 
environment and patient’s 
environment). 
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Table II shows the kinds of intra- and extra-BAN 
communications possible with the two systems. 
TABLE II.  COMMUNICATIONS 
PHM MobiHealth 
IntraBAN Communications 
Wired, wireless (Bluetooth) • Wired,/wireless 
(Bluetooth) 
ExtraBAN Communications 
• 3G, GSM, SMS, Internet. 
• Phone and SMS numbers 
can be personalised 
• GPRS, UMTS, WiFi, 
Internet, SMS. 
• Vertical handover between 
transmission technologies  
 
Table III shows the characteristics of the back end systems. 
TABLE III.  BACK END SYSTEM 
PHM MobiHealth 
Back End 
• Any ISP offering MS 
ASP.NET web hosting. 
• Generic interface for live 
data showing patients 
needing attention. 
• Generic interface for 
PHM administration. 
• Specific Interface for the 
specialist (cardiologist, 
PA). 
• BAN Back End runs on PC 
or laptop set up as Jini 
server. Jini Surrogate 
Architecture used to 
represent and manage 
BANs, BAN devices and 
BAN data and give 
physicians access to BAN 
data and management 
functions. Physician access 
is via a generic m-health 
portal (web application) 
customized for each 
clinical application 
Processing on Back End 
• Triage of life data which 
can be personalised to the 
application domain. 
• Viewing and reporting 
for physician. 
• Physician can update 
sensor thresholds. 
• Remote management of 
PHM equipment and 
patients. 
• Password protected 
viewing by the patient 
(limited view). 
• Synchronisation between 
MBU and Back End. 
• Generic BAN 
functionality. Application 
functionality specific to 
each individual clinical 
application and patient and 
HP user requirements. 
Generally, viewing, 
streaming and 
management services for 
BANs and BAN data, 
analysis and interpretation 
algorithms, alarms, 
geospatial and location-
based services. 
• HPs can switch on BANs 
and BAN devices, alter 
sampling frequencies etc. 
• Mechanisms for feedback 
and treatment from HPs. 
• Various security and 
access control 
mechanisms.  
IV. CLINICAL APPLICATIONS 
Table IV shows the trials conducted to date by the two 
teams in Australia and Europe and their clinical partners. 
 
 
 
TABLE IV.  CLINICAL TRIALS 
PHM MobiHealth 
Trial Patient group(s) 
• 1 trial group: 70+ cardiac 
patients. 
• Trial in one centre in 
Sydney. 
• English speaking, Multi- 
ethnicity, 22-90 years. 
• Low-medium risk 
• 17 trial groups over 4 
projects. 
• Multi centre international 
trials in Europe. 
• Multi-language. 
• Low risk patients. 
Clinical specialties/settings 
• Cardiology 
• General well being 
• Chronic disease 
management 
• Rehabilitation 
• Cardiology 
• Obstetrics 
• Trauma care 
• Rheumatology 
• Psychiatry 
• Pulmonary medicine 
• Gerontology 
• Neurology 
Clinical applications 
Monitoring:  
• Cardiac Rhythm 
Monitoring. 
• Cardiac rehabilitation. 
• Primary prevention. 
Telemonitoring: 
• Ventricular arrhythmia. 
• High risk pregnancies. 
• Acute trauma  
• Rheumatoid arthritis. 
• Recently discharged 
patients in remote 
locations. 
• Mental health problems. 
• COPD rehabilitation. 
• Elderly patients with co-
morbidities including 
COPD. 
• Epilepsy  
• Uncontrolled movements 
in spasticity. 
Telemonitoring/treatment: 
• chronic pain with 
whiplash and work-
related neck/shoulder pain 
A. Personal Health Monitor 
Applications currently available include Cardiac Rhythm 
Monitoring (CRM), Cardiac Rehabilitation and primary 
prevention. The CRM application aims at detecting cardiac 
arrhythmia events which are not always detected by a Holter 
or Event monitor due to their sporadic nature. The study also 
investigates the usability and practicability of the system 
from both patients’ and physicians’ perspectives. A 
secondary aim is to investigate whether use of the PHM 
provides clinically meaningful reassurance to patients with 
suspected arrhythmias and other cardiac conditions. 
The Cardiac rehabilitation application aims at remote 
monitoring of a patient’s progress by a physician as well as 
motivating the patient to do his/her exercises. Studies show 
that, in order to improve long term clinical outcomes, 
patients need to make lifestyle changes following myocardial 
infarction or coronary bypass surgery. Many fail to do so. 
We investigate whether the PHM system can aid and 
motivate patients to achieve these life style changes by 
giving reminders and monitoring progress. 
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B. MobiHealth BAN 
The mobile services provided can be characterized as 
telemonitoring or teletreatment services. Multi-centre 
international trials have been conducted in The Netherlands, 
Germany, Spain, Sweden and Cyprus. Different variants of 
the BAN have been trialled on a number of patient groups 
during the course of several research projects starting in 
2002 with the MobiHealth project. Patients with ventricular 
arrhythmias were monitored by a health call centre. They 
wore BANs designed to detect dangerous arrhythmias as 
well as longer term trends in cardiac function. Pregnant 
women were monitored in order to detect premature labour 
and foetal distress. In the trauma trials ambulance 
paramedics used paramedic BANs to transfer image 
information from the scene to the hospital and applied 
trauma patient BANs to casualties to transmit vital signs to 
the hospital. Physical activity monitoring of women with 
rheumatoid arthritis was conducted in order to gather 
research data. Patients recently discharged from hospital to 
remote rural locations were remotely monitored by a 
physician or a registered district nurse, with the objective of 
preventing unnecessary (re)hospitalizations. Patients with 
mental health and other problems supported by a home alarm 
system were given a BAN equipped with positioning and an 
alarm button. The objective was to support these patients 
outside the home, thus freeing them up to full mobility. 
COPD patients used BANs for monitoring at home and 
during outdoor exercise during rehabilitation. Another trial 
used telemonitoring in homecare for elderly chronically ill 
patients.  
Cardiac, pregnancy and COPD monitoring were further 
trialled during the HealthService24 project. In Awareness 
epilepsy patients, chronic pain patients and patients with 
uncontrolled movements in spasticity were monitored. With 
Myotel we introduce teletreatment. Teletreatment involves 
local biofeedback and advice from a remote clinician. 
Telemonitoring and treatment services are trialled on chronic 
pain patients including patients with whiplash and patients 
with work-related neck/ shoulder pain. 
V. EXPERIENCE WITH USERS 
To date 70 low-medium risk cardiac patients, aged 22 to 
90 years old used the PHM system at a Sydney Hospital 
(Cardiology Department). The patients were given a heart 
monitor and a mobile phone to monitor and record their 
cardiac rhythm for a few weeks in their normal environment. 
The trial has already demonstrated that the detection of 
important cardiac arrhythmias is feasible using the PHM 
system compared to conventional Holter monitors. The 
ECG signal quality is in the majority of cases of sufficient 
quality for a cardiologist to make an assessment. Patients 
are able to record their cardiac rhythm when they feel 
something and the PHM records automatically if it detects 
an abnormal rhythm. “Catching” an arrhythmia event 
greatly improves satisfaction for those patients for whom 
nothing showed up on an ECG taken by the cardiologist. 
Most patients had no difficulty using a mobile phone and 
ECG sensor and the PHM application is straightforward to 
use. All patients who had used a Holter monitor found the 
PHM far less intrusive and more practical. Patients leading 
an active life appreciated the fact no one could see they 
were wearing sensors and being monitored. 
A. European trials 
Our experience working with healthcare organizations 
and clinicians has been almost exclusively positive over the 
course of the BAN research. However the clinicians who 
initiate or join such projects are often the enthusiastic early 
adopters of technology, so are not necessarily representative 
of all their professional colleagues. Technical failures (such 
as system instability and loss of network connectivity), sub-
optimal interface design and a difficult (re)start sequence 
understandably cause irritation and confusion to users. 
Notwithstanding some such technical problems in the first 
generation prototypes the utility of the telemonitoring service 
was acknowledged by all classes of user: professionals and 
patients, who agreed that ‘a stable commercial product 
would be very useful’ and “the overall evaluation of the 
MobiHealth system showed that the need for, and 
advantages of, the system were clear to all users”. 
Preliminary results from Myotel indicate that continuous 
local biofeedback enables chronic pain patients to adapt their 
behaviour rapidly and results in long lasting treatment 
effects. Adding the telemedicine dimension with feedback 
from the remote therapist further improves clinical outcomes 
related to pain and disability. Patients reacted positively to a 
feature allowing them to view their biosignals in real time on 
the MBU and quickly learnt to ‘read’ the displays and use 
them to improve relaxation [3]. 
VI. DISCUSSION AND CONCLUSIONS 
The PHM system adopts the policy of local processing, 
with interpretation algorithms running locally on the mobile 
system worn by the patient. In contrast the MobiHealth BAN 
is designed to be inherently a telemedicine system so a core 
feature is transmission of data to a remote system or user. An 
added advantage of the distributed system is that more 
computationally expensive processing, which may exceed 
the capacity of the mobile device, can be applied at the 
server side. However delays and other complications may 
also arise through dependence on long range wireless links. 
The Australian team made a decision to focus on non-
invasive applications. For the European team, all 
applications so far have been non-invasive, but minimally 
invasive systems, including the use of implants, are not ruled 
out. The Australian PHM system originally aimed to provide 
personal mobile health services primarily for use by patients; 
later the back end web services for clinical users were added. 
In contrast, for the European team the teleservice aspect was 
central from the outset. The Australian PHM system targets 
personal monitoring specifically and associated disease and 
personal health management services, whilst the MobiHealth 
vision was always to provide m-health services for patients 
and health professionals by enabling virtual health care 
teams.  From the start the MobiHealth team aimed at 
teletreatment as well as telemonitoring. The European team 
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also included the notion of health professional BANS from 
the outset [2]. 
The European team began by defining a generic 
architecture for the MobiHealth BAN and its supporting 
system. The generic BAN is then specialised for each clinical 
application by integrating a specific set of devices and 
implementing the appropriate application functionality. In 
the current exercise, by applying the generic architecture we 
found that the concepts could be mapped onto the Australian 
PHM system and correspondences and differences could be 
identified by reference to that architecture.  
We express the generics using a layered architecture 
view, with the application specifics at the top layer. Where 
MobiHealth started with generics and moved to 
specialization, the PHM approach was to start with one 
clinical application and separate generic functionality from 
application details, then to transfer the generics from the first 
clinical application to other applications within cardiology. 
In contrast the MobiHealth BAN was applied in parallel to 
clinical settings from different specialties since the first 
prototype systems. The PHM system will be applied to other 
specialties than cardiology and already has other sensors 
integrated which can be reused in other applications (Weight 
scale, Blood Pressure monitor, Blood Glucose monitor and 
Pulse Oximeter). 
The emphasis on adaptability and genericity, and the 
level of ambition, together with the essential telemedicine 
dimension, come at the cost of a certain level of complexity, 
making the MobiHealth system relatively heavyweight 
compared to the PHM system, with its leaner, more light 
weight approach. 
Determinants for the success of telemedicine have been 
identified as (1) Technology, (2) Acceptance, (3) Financing, 
(4) Organization and (5) Policy and Legislation [7]. Since 
both the PHM and the MobiHealth BAN are targeting the 
same global market, we face the same challenges in terms of 
financing, policy and legislation. We therefore focus here on 
Technology and Acceptance. 
A. Technology 
The PHM uses off-the-shelf sensors. They are available 
on the market and their technology is mature. This means 
that to use the PHM for independent personal monitoring, a 
user only needs to have a Microsoft Windows Mobile phone, 
and to buy or rent the sensors. The user can then download 
the software onto the mobile phone and use it just like any 
other Windows Mobile application. Another advantage of 
using off the shelf sensors is that the health professionals 
trust those devices if they are FDA, TGA and/or CE, 
approved. Patients can claim sensor rental or purchase from 
Medicare or their private health insurance in some countries 
(e.g. in Australia, blood pressure and blood glucose monitors 
are reimbursed by health insurers).  
The PHM users had no real problem with the battery life 
of the mobile phone. Most people nowadays are used to 
recharging their phone regularly. The limited battery life of 
the mobile devices has been more problematic for the 
MobiHealth BAN due to the more experimental nature of the 
sensor front ends used. 
For the younger generation, using a mobile phone for 
local processing of sensor data is a natural choice. It might 
be expected that simpler devices would be more suitable for 
patients in their 70s or older. However, during the PHM 
trials, elderly patients were able to use the personal health 
monitoring application even if they never used a mobile 
phone before. Simplicity and motivation, not age, seem to be 
the key factors for technology acceptance. 
The European team always took the view that to support 
pervasive services and full mobility for the user extraBAN 
communication should be wireless. However, the PHM, with 
good reason, uses both wireless and wired communication 
extraBAN. The PHM has an option to use wired (USB) 
communication between phone and PC to allow 
synchronisation of non-urgent data with the web service over 
ADSL. It might seem strange to readers who are used to 
good wireless coverage but this is necessary in countries 
such as Australia where wireless coverage is patchy and/or 
costly.  
Both PHM and MobiHealth BAN provide secure web 
access to display data and present information using different 
views. The PHM team chose also to give patients access to 
some data. This allows them for example to check on their 
progress or to show their data to their GP. In the MobiHealth 
system, the emphasis has been on clinician access to data but 
patient access to data can be given depending on the 
application requirements. An example is the Myotel 
myofeedback BAN [3], which allows patients to view their 
biosignals real time on the MBU. 
MobiHealth BANs do not operate in isolation but are 
supported by an m-health service platform. We make a clear 
separation between the BAN Back End System and the 
clinical back end. The professional users at the clinical back 
end manage BANs and access BAN data via the m-health 
portal. A corollary is that the MobiHealth BAN cannot 
operate in standalone mode. In contrast the Australian 
system can operate standalone as a personal mobile service 
and can provide useful services in the absence of cell phone 
coverage. The PHM system works even if none of the 
designated sensors are connected. 
The development environment used for the PHM is C# 
and .NET compact framework, so the PHM system is tied 
into Microsoft’s Windows Mobile operating system. 
However the system can be deployed onto any mobile phone 
running Windows Mobile and patients can be offered a range 
of phones. In the European solution, Java technology was 
selected for reasons of portability and platform 
independence, so in theory the system can be implemented 
on any mobile platform capable of running JVM and RMI. 
There may be some overhead cost associated with running 
non-native code. 
B. Acceptance 
Clinicians found the European system presents clinical 
information of diagnostic quality and both patients and 
clinicians saw the utility of the telemedicine services, 
providing the system was stable. Beyond this, evaluation 
results are specific to clinical settings and space does not 
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permit review here. Detailed evaluation results are available 
for all trials at the project websites. 
The Australian trials showed that, for acceptance by 
patients and health professionals, it was important for the 
system to be useful, easy to use and personalised. Reliability 
and accuracy were essential for professional acceptance. 
CRM patients found the PHM helped them to obtain a better 
diagnosis of their chronic condition. Some patients would 
have liked to keet the PHM since it gave them peace of 
mind.  
The cardiologists confirmed that the data was of 
sufficient quality to identify the main arrhythmias and 
pauses. They found the PHM very useful for a category of 
patients who do not get symptoms during their visit to the 
specialist, and for people who faint for no apparent reason 
(syncope). Thanks to the recordings, they can for example 
find out the cause of the fainting and its duration. The 
cardiologist also makes a better impression on his patients 
suffering from chronic conditions. Instead of saying ‘sorry, I 
suspect you have this but I cannot confirm it without 
evidence’ he can refer to the PHM trials and say: ’use this 
and try and record the event’.  
The patients who used the PHM to monitor their 
wellbeing found it useful to be in charge of their health and 
keep track of their progress (e.g. they can work out what 
triggers changes in blood pressure). CRM patients found the 
PHM far less intrusive and more practical than the Holter 
monitor. During the trials the PHM back end was specialised 
to suit the requirements of a cardiologist (he can annotate 
ECGs, print reports etc.). This makes PHM a useful tool for 
cardiologists. 
Each user has different needs and preferences so it is 
important for the applications to be tailorable to patients’ and 
health professionals’ needs and requirements. The PHM 
trials highlighted that feedback not only depends on the 
clinical application but also on patient preferences. Some 
patients want to be in charge of their health, are aware of 
medical terminology and wish to get immediate feedback. 
Others prefer to use the application without any interaction 
because they do not wish to know what is happening as they 
find it stressful. Elderly patients living alone want audio 
reminders and warnings. Active people want the application 
to be as unobtrusive as possible. The flexibility of the PHM 
user interface allows personalisation of feedback to the user. 
Overall, we can say that the MobiHealth system, which 
has been in development for longer than the PHM, is a 
complex but generic distributed system mediating between 
patients and healthcare organisations and designed for 
provision of a wide range of telemedicine services. The 
PHM system was originally focussed on a specific 
application relating to patient self-care, but is extending by 
evolutionary development both vertically (additional 
applications) and horizontally (by developing the clinical 
back end).  
In the introduction we identified some dimensions 
whereby m-health services may be classified. MobiHealth 
focussed on physician care and remote processing whereas 
PHM focussed on patient self-care and local processing. 
PHM deals with monitoring, the latest MobiHealth BAN in 
Myotel with monitoring and treatment. PHM tended initially 
toward patient interaction and MH to transparent services at 
the patient’s end. PHM began with acute applications whilst 
MH targeted both acute and chronic care. 
This article shows that the two teams are applying 
different design and technology choices, and addressing 
different focal points (telemedicine versus personal health 
management). Despite the differences in technologies and 
approach to generic m-health service provision, the two 
systems however are converging in relation to most of the 
identified dimensions. 
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